Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Infection
- Vol. 80 (6), E19-E26
- https://doi.org/10.1016/j.jinf.2020.03.003
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81800010/81525016/81671984)
- Guangdong Provincial Science and Technology Program (2019B030301009)
This publication has 34 references indexed in Scilit:
- Advances in the development of new tuberculosis drugs and treatment regimensNature Reviews Drug Discovery, 2013
- TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen SpeciesCell, 2013
- The Hairpin-type Tail-Anchored SNARE Syntaxin 17 Targets to Autophagosomes for Fusion with Endosomes/LysosomesCell, 2012
- Extracellular M. tuberculosis DNA Targets Bacteria for Autophagy by Activating the Host DNA-Sensing PathwayCell, 2012
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature, 2011
- Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosisCell, 2010
- Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected MacrophagesCell, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsThe New England Journal of Medicine, 2003
- Effect of Rifampin on Apparent Clearance of EverolimusAnnals of Pharmacotherapy, 2002
- Global Burden of TuberculosisJAMA, 1999